A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

  1. Martínez-Terroba, E.
  2. Behrens, C.
  3. de Miguel, F.J.
  4. Agorreta, J.
  5. Monsó, E.
  6. Millares, L.
  7. Sainz, C.
  8. Mesa-Guzman, M.
  9. Pérez-Gracia, J.L.
  10. Lozano, M.D.
  11. Zulueta, J.J.
  12. Pio, R.
  13. Wistuba, I.I.
  14. Montuenga, L.M.
  15. Pajares, M.J.
Aldizkaria:
Journal of Pathology

ISSN: 1096-9896 0022-3417

Argitalpen urtea: 2018

Alea: 245

Zenbakia: 4

Orrialdeak: 421-432

Mota: Artikulua

DOI: 10.1002/PATH.5096 GOOGLE SCHOLAR